<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146435">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02084186</url>
  </required_header>
  <id_info>
    <org_study_id>81303033</org_study_id>
    <nct_id>NCT02084186</nct_id>
  </id_info>
  <brief_title>Moxibustion for Mild and Moderate Ulcerative Colitis</brief_title>
  <official_title>The Mechanism of Moxibustion in Treating Ulcerative Colitis Based on Metabonomics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Institute of Acupuncture, Moxibustion and Meridian</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Institute of Acupuncture, Moxibustion and Meridian</source>
  <oversight_info>
    <authority>China: National Natural Science Foundation</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether moxibustion is effective to mild and
      moderate ulcerative colitis and the effect of moxibustion on metabolism.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>disease activity index (DAI)</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Using Mayo subscore</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammatory Bowel Disease Questionnaire (IBDQ)</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom score</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>histomorphology observation of intestinal mucosa</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Using the Geboes histology score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>metabolic profile of intestinal mucosa, urine, plasma and serum</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>moxibustion group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>herb-partitioned moxibustion on bilateral Tianshu (ST25) and Shangjuxu (ST37)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bran-partitioned moxibustion</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>bran-partitioned moxibustion on bilateral Tianshu (ST25) and Shangjuxu (ST37)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>herb-partitioned moxibustion</intervention_name>
    <description>Ignited moxa cones are placed upon herbal cake. Herbs are smashed into powder. Every 2.8g medicine powder mix with 3g millet wine and then be pressed into herbal cakes which are 28mm in diameter and 7mm in high with a specific mould. Then the herbal cake with a moxa cone will be fixed on Tianshu and Shangjuxu.</description>
    <arm_group_label>moxibustion group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>bran-partitioned moxibustion</intervention_name>
    <description>Ignited moxa cones are placed upon bran cake. Every 2.8g bran powder mix with 3g millet wine and then be pressed into bran cakes which are 28mm in diameter and 7mm in high with a specific mould. Then the bran cake with a moxa cone will be fixed on Tianshu and Shangjuxu.</description>
    <arm_group_label>bran-partitioned moxibustion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Meet the diagnosis of UC

          -  Mayo â‰¤10

          -  Patients should have never received any pharmacological therapy or if they are
             receiving aminosalicylates and/or prednisolone (the dosage has been taken at least 4
             weeks, and should be kept the same as before throughout the trial)

          -  Patients should have never received antibiotic, biologicals, probiotics,
             acetaminophen, acetamide and contraceptive.

          -  A written informed consent

        Exclusion Criteria:

          -  Patients with cardiac, encephalic, hepatic, nephric, hematopoietic system,
             psychotic or any other serious diseases

          -  Pregnancy or lactation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huangan Wu, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Shanghai Institute of Acupuncture-Moxibustion and Meridian, Shanghai University of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Huangan Wu, Doctor</last_name>
    <phone>021-64644238</phone>
    <email>wuhuangan@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai Institute of Acupuncture-Moxibustion and Meridian</name>
      <address>
        <city>Shanghai</city>
        <zip>200030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 16, 2014</lastchanged_date>
  <firstreceived_date>March 9, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
